QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

AMPH

QT81Amphastar Pharmaceuticals, Inc.
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·USA
Latest market price
18.81
-0.60-3.09%
OverviewShort InterestFilings
AMPHQT81Amphastar Pharmaceuticals, Inc.·NASDAQ
OverviewShort InterestFilings
18.81-3.09%
TA
Loading chart...
Screen all →
TAK+1.36%$15.63HLN+1.01%$8.96TEVA-3.32%$31.48VTRS-2.29%$15.37ELAN+3.55%$24.22RDY+1.06%$13.29RGC-18.96%$12.01LNTH+0.65%$103.86
Snapshot
Index-P/E11.10EPS (ttm)
1.66
Insider Own13.96%
Shs Outstand44.09M
Perf Week-8.38%
Market Cap855.84MForward P/E5.98EPS next Y3.14Insider Trans0.00%Shs Float-Perf Month5.56%
Enterprise Value1.37BPEG-EPS next Q-Inst Own-Short Float-Perf Quarter-3.74%
Income77.11MP/S1.19EPS this Y61.50%Inst Trans-Short Ratio-Perf Half Y-26.55%
Sales720.54MP/B1.14EPS next Y17.24%ROA4.81%Short Interest-Perf YTD-29.76%
Book/sh17.53P/C5.21EPS next 5Y-2.13%ROE10.23%52W High31.26 -39.83%Perf Year-26.55%
Cash/sh6.67P/FCF6.33EPS past 3/5Y5.27% 134.54%ROIC6.02%52W Low16.65 12.97%Perf 3Y-
Dividend Est.-EV/EBITDA7.16Sales past 3/5Y13.00% 15.52%Gross Margin47.34%Volatility3.11% 2.69%Perf 5Y-
Dividend TTM-EV/Sales1.90EPS Y/Y TTM-Oper. Margin16.20%ATR (14)0.85Perf 10Y-
Dividend Ex-DateJun 11, 2010Quick Ratio2.82Sales Y/Y TTM-1.64%Profit Margin11.00%RSI (14)44.31Recom3.00
Dividend Gr. 3/5Y-Current Ratio3.85EPS Q/Q-SMA20-2.14%Beta0.97Target Price20.50
Payout0.00%Debt/Eq0.89Sales Q/Q0.00%SMA50-6.50%Rel Volume2.08Prev Close19.41
Employees2,028LT Debt/Eq0.82Earnings-SMA200-21.72%Avg Volume638.23KPrice18.81
IPO DateJun 25, 2014Option/ShortYes / YesEPS/Sales Surpr.-Net Debt/EBITDA2.69Volume1,327,567Change-3.09%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-03-26ReiteratedBarclaysEqual Weight$30 → $20
May-14-26DowngradeWells FargoOverweight → Equal Weight$19
May-11-26ReiteratedPiper SandlerNeutral$32 → $21
May-08-26DowngradeNeedhamBuy → Hold
Apr-21-26DowngradeJefferiesBuy → Hold$22
Dec-08-25InitiatedBarclaysEqual Weight$30
Aug-12-25UpgradeNeedhamHold → Buy
May-12-25DowngradeJP MorganOverweight → Neutral
Mar-21-25ReiteratedPiper SandlerNeutral$66 → $32
Feb-04-25DowngradePiper SandlerOverweight → Neutral
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue720720732
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A379364358
Gross Profit341356374
Selling, General and Administrative Excl. Other13213095
Research and Development928674
Other Operating Expense00-1
Operating Income117140205
Interest Expense262530
Unusual Expense
———
Non-Operating Income (Expense)-11-9-15
Net Income Before Taxes103124189
Income Taxes232630
Consolidated Net Income7898160
Net Income From Continuing Operations7898160
Net Income7898160
EPS (Recurring)1.712.103.29
EPS (Basic, Before Extraordinaries)1.712.103.29
EPS (Diluted)1.662.033.06
EBITDA192212277
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio11.3313.19—
Price To Sales Ratio1.181.75—
Gross Margin47.3649.4451.09
Operating Margin16.2519.4428.01
Net Margin10.8313.6121.86
Shares Outstanding454748
Market Capitalization8461,259—
Operating Lease Expense
———
Insider Trading Volume
$21.47$20.39$19.30$18.21$17.13● Close Price0.00K141.93K283.86K425.79K567.72KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Zhou RongSENIOR EVP, PRODUCTION CENTERDec 17 '25Option Exercise11.3319,574221,774147,830Dec 18 12:00 AM
Zhou RongSENIOR EVP, PRODUCTION CENTERDec 17 '25Sale26.209,787256,379138,043Dec 18 12:00 AM
Petersen Floyd F.DirectorDec 12 '25Sale25.922,42662,88871,368Dec 15 12:00 AM
Petersen Floyd F.DirectorDec 11 '25Sale25.691,73744,62073,794Dec 15 12:00 AM
PRINS RICHARD KDirectorNov 25 '25Option Exercise16.698,358139,49639,362Nov 25 12:00 AM
PRINS RICHARD KDirectorNov 25 '25Sale27.104,179113,25335,183Nov 25 12:00 AM
Petersen Floyd F.DirectorNov 13 '25Option Exercise16.6933,358556,74692,210Nov 17 12:00 AM
Petersen Floyd F.DirectorNov 13 '25Sale26.4916,679441,83775,531Nov 17 12:00 AM
Petersen Floyd F.DirectorNov 03 '25Sale25.2750012,63375,531Nov 05 12:00 AM
Petersen Floyd F.DirectorOct 01 '25Sale27.2050013,60276,031Oct 02 12:00 AM
Petersen Floyd F.DirectorSep 02 '25Sale30.9850015,49276,531Sep 03 12:00 AM
Petersen Floyd F.DirectorAug 01 '25Sale20.8350010,41677,031Aug 04 12:00 AM
Petersen Floyd F.DirectorJul 02 '25Sale23.4750011,73477,531Jul 03 12:00 AM
Zhang Jack Y.CEO & CHIEF SCIENTIFIC OFFICERJun 13 '25Option Exercise13.03400,0005,212,0002,847,659Jun 16 12:00 AM
Petersen Floyd F.DirectorJun 02 '25Sale25.6750012,83572,909Jun 04 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR